New drug development for neglected diseases: a bibliometric analysis
DOI:
https://doi.org/10.29397/reciis.v16i2.2380Keywords:
Drug development, Drug design, Scientific research and technological development, Neglected diseases, Bibliometrics.Abstract
Neglected diseases impose a devastating human, social, and economic burden on more than one billion people worldwide. While tools exist to control and even eliminate many of these diseases, new therapeutic products urgently need to be developed. This article is based on a study that sought to quantify and characterize the global scientific production on new drug development for neglected diseases through a bibliometric analysis. The Scopus database was used to investigate the research related to the development of new drugs for neglected diseases globally in the last decade. An increase in the production of knowledge about the theme and the relevant participation of Brazilian authors, institutions and funding, especially from public institutions were observed. However, their efforts have been insufficient, and the implementation of future research and funding strategies that provide greater scientific production and a translation of basic research into clinical practice is necessary.References
ARAUJO, Renan Vinícius de et al. Malária e tuberculose como doenças de populações negligenciadas: estado da arte em quimioterapia e avanços na busca por novos medicamentos. Memórias do Instituto Oswaldo Cruz, Rio de Janeiro, v. 115, p. e200229, 2020. DOI: https://doi.org/10.1590/0074-02760200229. Disponível em: https://www.scielo.br/scielo.php?script=sci_abstract&pid=S0074-02762020000100201&lng=pt&nrm=iso&tlng=pt. Acesso em 28 abr. 2021.
ALRYALAT, Saif Aldeen et al. The impact of the open-access status on journal indices: a review of medical journals. F1000Research, Londres, v. 8, p. 266, 2019. DOI: https://doi.org/10.12688/f1000research.17979.1. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449789/. Acesso em: 24 abr. 2021.
BAI, Jing et al. Bibliometric study of research and development for neglected diseases in the BRICS. Infectious Diseases of Poverty, [s. l.], v. 5, n. 89, 2016. DOI: https://doi.org/10.1186/s40249-016-0182-1. Disponível em: https://idpjournal.biomedcentral.com/articles/10.1186/s40249-016-0182-1. Acesso em: 23 mar. 2021.
BALASEGARAM, Manica et al. A global biomedical R&D fund and mechanism for innovations of public health importance. PLoS Medicine, São Franscico, v. 12, n. 5, p. e1001831, 2015. DOI: https://doi.org/10.1371/journal.pmed.1001831. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427184/ . Acesso em: 02 maio 2021.
BOLZANI, Vanderlei da Silva. Biodiversidade, bioprospecção e inovação no Brasil. Ciência e Cultura, São Paulo, v. 68, n. 1, p. 04-05, 2016. DOI: http://dx.doi.org/10.21800/2317-66602016000100002. Disponível em: http://cienciaecultura.bvs.br/scielo.php?script=sci_arttext&pid=S0009-67252016000100002. Acesso em: 01 maio 2021.
BRASIL. Doenças negligenciadas: estratégias do Ministério da Saúde. Revista de Saúde Pública, São Paulo, v. 44, n. 1, p. 200+-202, 2010. DOI: https://doi.org/10.1590/S0034-89102010000100023. Disponível em: https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102010000100023#:~:text=Por%20meio%20de%20dados%20epidemiol%C3%B3gicos,%2C%20mal%C3%A1ria%2C%20esquistossomose%20e%20tuberculose. Acesso em: 28 abr. 2021.
BREUGELMANS, J. Gabrielle et al. Bibliometric assessment of European and Sub-Saharan African research output on poverty-related and neglected infectious diseases from 2003 to 2011. PLoS Neglected Tropical Disease, São Francisco, v. 9, n. 8, p. e0003997, 2015. DOI: https://doi.org/10.1371/journal.pntd.0003997. Disponível em: https://pubmed.ncbi.nlm.nih.gov/26262756/. Acesso em: 23 mar. 2021.
CAMPOS, Kevin et al. The importance of synthetic chemistry in the pharmaceutical industry. Science, Londres, v. 363, n. 244, p. eaat0805, 2019. DOI: https://doi.org/10.1126/science.aat0805. Disponível em: https://www.science.org/doi/10.1126/science.aat0805. Acesso em 02 maio 2021.
CHATELAIN, Eric; IOSET, Jean-Robert. Drug discovery and development for neglected diseases: the DNDi model. Drug Design, Development and Therapy, Londres, v. 5, p. 175-81, 2011. DOI: https://doi.org/10.2147/DDDT.S16381. Disponível em: https://pubmed.ncbi.nlm.nih.gov/21552487/. Acesso em: 06 maio 2021.
CRUZ-CALDERÓN, Stefani et al. A bibliometric analysis of global Ebola research. Travel Medicine and Infectious Disease, [s. l.], v. 13, n. 2, p. 202-204, 2015. DOI: https://doi.org/10.1016/j.tmaid.2015.02.007. Disponível em: https://www.sciencedirect.com/science/article/pii/S1477893915000344?via%3Dihub. Acesso em: 02 abr. 2021.
DELGADO-OSORIO, Nathália et al. Bibliometric assessment of the contributions of literature on Chagas disease in Latin America and the Caribbean. Recent Patents on Anti-Infective Drug Discovery, Amsterdam, v. 9, n. 3, p. 202-208, 2014. DOI: https://doi.org/10.2174/1574891x10666150410154322. Disponível em: https://pubmed.ncbi.nlm.nih.gov/25858262/. Acesso em: 23 abr. 2021.
ESCOBEDO, Angel A. et al. Um estudo bibliométrico da produtividade científica internacional em giardíase cobrindo o período de 1971-2010. The Journal of Infection in Developing Countries, [s. l.], v. 9, n. 1, p. 76-86, 2015. DOI: https://doi.org/10.3855/jidc.5785. Disponível em: https://pubmed.ncbi.nlm.nih.gov/25596575/. Acesso em: 02 abr. 2021.
FLEMING, Nic. How artificial intelligence is changing drug Discovery. Nature, Londres, v. 557, n. 7707, p. s55-s57, 2018. DOI: https://doi.org/10.1038/d41586-018-05267-x. Disponível em: https://pubmed.ncbi.nlm.nih.gov/29849160/ . Acesso em: 02 maio 2021.
FONSECA, Bruna de Paula; ALBUQUERQUE, Priscila Costa; ZICKER, Fábio. Neglected tropical diseases in Brazil: lack of correlation between disease burden, research funding and output. Tropical Medicine and International Health, Londres, v. 25, n. 11, p. 1373-1384, 2020. DOI: https://doi.org/10.1111/tmi.13478. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32860446/. Acesso em: 28 abr. 2021.
GIAROLLA, Jeanine; FERREIRA, Elizabeth Igne. Drug design for neglected disease in Brazil, Mini-Reviews in Medicinal Chemistry, Hilversum, v. 15, n. 3, p. 220-242, 2015.DOI: https://doi.org/10.2174/138955751503150312122523 Disponível em: https://pubmed.ncbi.nlm.nih.gov/25769971/. Acesso em: 29 abr. 2021.
GUIDO, Rafael V. C.; ANDRICOPULO, Adriano D.; OLIVA, Glaucius. Planejamento de fármacos, biotecnologia e química medicinal: aplicações em doenças infecciosas. Estudos Avançados, São Paulo, v. 24, n. 70, p. 81-98, 2010. DOI: http://dx.doi.org/10.1590/S0103-40142010000300006. Disponível em: https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-40142010000300006. Acesso em: 02 abr. 2021.
HASENCLEVER, Lia et al. A indústria de fitoterápicos brasileira: desafios e oportunidades. Ciência & Saúde Coletiva, Rio de Janeiro, v. 22, n. 8, p. 2559-2569, 2017. DOI: https://doi.org/10.1590/1413-81232017228.29422016. Disponível em: https://www.scielo.br/scielo.php?pid=S1413-81232017002802559&script=sci_abstract&tlng=pt. Acesso em: 01 maio 2021.
HERNANDEZ, Helen W. et al. High Throughput and Computational Repurposing for Neglected Diseases. Pharmaceutical Research, Nova York, v. 36, n. 2, p. 27, 2018. DOI: https://doi.org/10.1007/s11095-018-2558-3. Disponível em: https://pubmed.ncbi.nlm.nih.gov/30560386/. Acesso em: 02 jun. 2020.
HINOSHITA, Eiji. Industry, academia and government partnership through the Global Health Innovative Technology Fund (GHIT). Yakugaku Zasshi, Tóquio, v. 136, n. 2, 2016. DOI: https://doi.org/10.1248/yakushi.15-00233-5. Disponível em: https://pubmed.ncbi.nlm.nih.gov/26831799/. Acesso em: 23 mar. 2021.
HOTEZ, Peter J.; FUJIWARA, Ricardo T. Brazil's neglected tropical diseases: an overview and a report card. Microbes and Infection, [s. l.], v. 16, n. 8, p. 601-606, 2014. DOI: https://doi.org/10.1016/j.micinf.2014.07.006. Disponível em: https://www.sciencedirect.com/science/article/pii/S1286457914000938?via%3Dihub. Acesso em: 06 abr. 2021.
HOTEZ, Peter J.; PECOUL, Bernard. "Manifesto" for advancing the control and elimination of neglected tropical diseases. PLoS Neglected Tropical Disease, Londres, v. 4, n. 5, p. e718, 2010. DOI: https://doi.org/10.1371/journal.pntd.0000718. Disponível em: https://pubmed.ncbi.nlm.nih.gov/20520793/. Acesso em: 23 mar. 2021.
HOTEZ, Peter J. et al. Eliminating the Neglected Tropical Diseases: Translational Science and New Technologies. PLoS Neglected Tropical Disease, Londres, v. 10, n. 3, p. e0003895, 2016. DOI: https://doi.org/10.1371/journal.pntd.0003895. Disponível em: https://pubmed.ncbi.nlm.nih.gov/26934395/. Acesso em: 02 maio 2021.
IYANDEMYE, Jonathan; THOMAS, Marshall P. Low income countries have the highest percentages of open access publication: A systematic computational analysis of the biomedical literature. PLoS One, São Francisco, v. 14, n. 7, p. e0220229, 2019. DOI: https://doi.org/10.1371/journal.pone.0220229. Disponível em: https://pubmed.ncbi.nlm.nih.gov/31356618/. Acesso em: 23 mar. 2021.
JIN, Guangxu; WONG, Stephen T. C. Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines. Drug Discovery Today, Oxford, v. 19, n. 5, 2014. DOI: https://doi.org/10.1016/j.drudis.2013.11.005. Disponível em: https://pubmed.ncbi.nlm.nih.gov/24239728/. Acesso em: 23 abr. 2021.
KAISER, Marcel et al. Antiprotozoal activity profiling of approved drugs: a starting point toward drug repositioning. PloS One, São Francisco, v. 10, n. 8, p. e0135556, 2015. DOI: https://doi.org/10.1371/journal.pone.0135556. Disponível em: https://pubmed.ncbi.nlm.nih.gov/26270335/. Acesso em: 23 abr. 2021.
KEATING, Conrad. Ken Warren and the Rockefeller Foundation’s great neglected diseases network, 1978–1988: the transformation of tropical and global medicine. Molecular Medicine, Cambridge, v. 20, suppl. 1, p. S24-30, 2014. DOI: https://doi.org/10.2119/molmed.2014.00221. Disponível em: https://pubmed.ncbi.nlm.nih.gov/25549230/. Acesso em: 23 mar. 2021.
LEPESHEVA, Galina I. et al. VFV as a New Effective CYP51 Structure-Derived Drug Candidate for Chagas Disease and Visceral Leishmaniasis. The Journal of Infectious Diseases, Oxford, v. 212, n. 9, p. 1439-1448, 2015. DOI: https://doi.org/10.1093/infdis/jiv228. Disponível em: https://pubmed.ncbi.nlm.nih.gov/25883390/. Acesso em: 23 abr. 2021.
MCMANUS, Concepta; NEVES, Abílio Afonso Baeta. Funding research in Brazil. Scientometrics, [s. l.], v. 126, p. 801-823, 2021. DOI: https://doi.org/10.1007/s11192-020-03762-5. . Disponível em: http://link.springer.com/10.1007/s11192-020-03762-5. Acesso em: 23 abr. 2021.
MOREL, Carlos Medicis. Health innovation networks to help developing countries address neglected diseases. Science, Londres, v. 309, n. 5733, p. 401-404, 2005. DOI: https://doi.org/10.1126/science.1115538. Disponível em: https://pubmed.ncbi.nlm.nih.gov/16020723/. Acesso em: 23 mar. 2021.
MOTA, Fabio Batista et al. Mapping the dengue scientific landscape worldwide: a bibliometric and network analysis. Memória do Instituto Oswaldo Cruz, Rio de Janeiro, v. 112, n. 5, p. 354-363, 2017. DOI: https://doi.org/10.1590/0074-02760160423. Disponível em: https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762017000500354. Acesso em: 24 mar. 2021.
OLIVEIRA, Roberta Gondim. Meanings of Neglected Diseases in the Global Health agenda: the place of populations and territories. Ciência & Saúde Coletiva, Rio de Janeiro, v. 23, n. 7, p. 2291-2302, 2018. DOI: https://doi.org/10.1590/1413-81232018237.09042018. Disponível em: https://www.scielo.br/scielo.php?pid=S1413-81232018000702291&script=sci_arttext&tlng=en. Acesso em: 24 mar. 2021.
ORGANIZAÇÃO DAS NAÇÕES UNIDAS (ONU). Transformando nosso mundo: a Agenda 2030 para o Desenvolvimento Sustentável. Brasília, DF: ONU, 2015. Disponível em: https://www.mds.gov.br/webarquivos/publicacao/Brasil_Amigo_Pesso_Idosa/Agenda2030.pdf. Acesso em 06 maio 2021.
PERILLA-GONZALEZ, Yuliana et al. Study of the scientific production on leishmaniasis in Latin America. Recent Patents on Anti-Infective Drug Discovery, Amsterdã, v. 9, n. 3, p. 216-222, 2014. DOI: https://doi.org/10.2174/1574891X10666150410165445. Disponível em: https://pubmed.ncbi.nlm.nih.gov/25858270/. Acesso em: 23 abr. 2021.
PIMENTEL, Vitor et al. Biodiversidade brasileira como fonte da inovação farmacêutica: uma nova esperança?. Revista do Banco Nacional de Desenvolvimento Econômico e Social, Rio de Janeiro, n. 43, p. 41-89, 2015. Disponível em: https://web.bndes.gov.br/bib/jspui/handle/1408/5602. Acesso em: 02 maio 2021.
POLICY CURES RESEARCH. Neglected disease research and development: where to now?. Sydney: G-Finder, 2020. Disponível em: https://policy-cures-website-assets.s3.ap-southeast-2.amazonaws.com/wp-content/uploads/2021/04/15055816/G-FINDER-2020_Final-Report.pdf. Acesso em 23 abr. 2021.
SCOPUS. Content Coverage Guide. Amsterdã: Elsevier, atualizado em 2020. Disponível em:https://www.elsevier.com/__data/assets/pdf_file/0007/69451/Scopus_ContentCoverage_Guide_WEB.pdf Acesso em 23 mar. 2021.
SIDONE, Otávio José Guerci; HADDAD, Eduardo Amaral; MENA-CHALCO, Jesús Pascual. A ciência nas regiões brasileiras: evolução da produção e das redes de colaboração científica. Transinformação, Campinas, v. 28, n. 1, p. 15-32, 2016. DOI: https://doi.org/10.1590/2318-08892016002800002 Disponível em: https://www.scielo.br/scielo.php?pid=S0103-37862016000100015&script=sci_abstract&tlng=pt. Acesso em: 23 mar. 2021.
SOBRAL, Natanael Vitor; MIRANDA, Zeny de Duarte; SILVA, Fabio Mascarenhas. Estratégia para a recuperação de informação científica sobre as doenças tropicais negligenciadas: análise comparativa da Scopus, PubMed e Web of Science. Revista Cubana de Información en Ciencias de la Salud, Havana, v. 29, n. 1, p. 74-91, 2018. Disponível em: http://scielo.sld.cu/scielo.php?script=sci_abstract&pid=S2307-21132018000100006&lng=es&nrm=iso&tlng=pt. Acesso em: 23 mar. 2021.
SOOSARAEI Masoud et al. A decade bibliometric analysis of global research on leishmaniasis in Web of Science database. Annals of Medicine and Surgery, Londres, v.16, p. 30-37, 2018. DOI: https://doi.org/10.1016/j.amsu.2017.12.014. Disponível em: https://pubmed.ncbi.nlm.nih.gov/29387384/. Acesso em: 24 abr. 2021.
VASCONCELLOS, Alexandre Guimarães; FONSECA, Bruna de Paula Fonseca; MOREL, Carlos Medicis. Revisiting the concept of Innovative Developing Countries (IDCs) for its relevance to health innovation and neglected tropical diseases and for the prevention and control of epidemics. PLoS Neglcted Tropical Disease, Londres, v. 12, n. 7, p. e0006469, 2018. DOI: https://doi.org/10.1371/journal.pntd.0006469. Disponível em: https://pubmed.ncbi.nlm.nih.gov/30001318/. Acesso em: 24 abr. 2021.
VERA-POLANIA, Felipe et al. Bibliometric assessment of scientific production of literature on chikungunya. Journal of Infection and Public Health, Oxford, v. 8, n. 4, p. 386-388, 2015. DOI: https://doi.org/10.1016/j.jiph.2015.03.006. Disponível em: https://pubmed.ncbi.nlm.nih.gov/25937447/. Acesso em: 23 mar. 2021.
WEAVER, Scott C. et al. Zika virus: History, emergence, biology, and prospects for
control. Antiviral Research, Amsterdã, v. 130, p. 69-80, 2016. DOI: https://doi.org/10.1016/j.antiviral.2016.03.010.
Disponível em: https://pubmed.ncbi.nlm.nih.gov/26996139/. Acesso em: 19 abr. 2021.
WENG, Hong-Bo; CHEN, Hai-Xia; WANG, Ming-Wei. Innovation in neglected tropical disease drug discovery and development. Infectious Diseases of Proverty, [s. l.], v. 7, n. 1, p. 67, 2018. DOI: https://doi.org/10.1186/s40249-018-0444-1. Disponível em: https://pubmed.ncbi.nlm.nih.gov/29950174/. Acesso em: 18 maio 2019.
WISE, Jacqui. Spending on research into neglected disease reached record high in 2017. The BMJ, Londres, v. 364, p. l303, 2019. DOI: https://doi.org/10.1136/bmj.l303. Disponível em: https://pubmed.ncbi.nlm.nih.gov/30679187/. Acesso em: 23 abr. 2021.
WORLD HEALTH ORGANIZATION (WHO). Accelerating work to overcome the global impact of neglected tropical diseases: a roadmap for implementation. Genebra: WHO, 2012. Disponível em: https://www.who.int/neglected_diseases/NTD_RoadMap_2012_Fullversion.pdf. Acesso em: 06 maio 2021.
WORLD HEALTH ORGANIZATION (WHO). WHO statement on the first meeting of the International Health Regulations (2005) (IHR 2005) Emergency Committee on Zika virus and observed increase in neurological disorders and neonatal malformations. Genebra: WHO, 2016. Disponível em: https://www.who.int/news/item/01-02-2016-who-statement-on-the-first-meeting-of-the-international-health-regulations-(2005)-(ihr-2005)-emergency-committee-on-zika-virus-and-observed-increase-in-neurological-disorders-and-neonatal-malformations. Acesso em: 19 abr. 2021.
WORLD HEALTH ORGANIZATION (WHO). Integrating neglected tropical diseases into global health and development: fourth WHO report on neglected tropical diseases. Genebra: WHO, 2017a. Disponível em: https://apps.who.int/iris/handle/10665/255011. Acesso em: 06 maio 2021.
WORLD HEALTH ORGANIZATION (WHO). TDR strategy 2018-2023: building the science of solutions. Geneva: World Health Organization; 2017b. Disponível em: https://www.who.int/tdr/publications/about-tdr/strategy/strategy-2018-23/en/. Acesso em 06 maio 2021.
WORLD HEALTH ORGANIZATION (WHO). Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021–2030. Geneva: WHO, 2020. Disponível em: https://apps.who.int/iris/handle/10665/338565 . Acesso em 25 abr. 2021.
YAMADA, Haruki; HIRABAYASHI, Fumiko; BRÜNGER, Chris. [International Partnership for Therapeutic Drug Development of NTDs by DNDi. Yakugaku Zasshi, Tóquio, v. 136, n. 2, p. 213-222, 2016. DOI: https://doi.org/10.1248/yakushi.15-00233-2. Disponível em: https://pubmed.ncbi.nlm.nih.gov/26831796/. Acesso em: 23 mar. 2021.
Downloads
Published
How to Cite
Issue
Section
License
Author’s rights: The author retains unrestricted rights over his work.
Rights to reuse: Reciis adopts the Creative Commons License, CC BY-NC non-commercial attribution according to the Policy on Open Access to Knowledge by Oswaldo Cruz Foundation. With this license, access, download, copy, print, share, reuse, and distribution of articles is allowed, provided that it is for non-commercial use and with source citation, granting proper authorship credits and reference to Reciis. In such cases, no permission is required from the authors or editors.
Rights of authors’s deposit / self-archiving: The authors are encouraged to deposit the published version, along with the link of their article in Reciis, in institutional repositories.
